Changes

Jump to navigation Jump to search

Off-label (view source)

Revision as of 19:20, September 25, 2022

166 bytes added ,  19:20, September 25, 2022
more
Line 3: Line 3:  
Estimates are that 21% of all prescriptions are off-label, and an even higher percentage of 36.2% of medications in intensive care units are off-label.
 
Estimates are that 21% of all prescriptions are off-label, and an even higher percentage of 36.2% of medications in intensive care units are off-label.
   −
As of September 25, 2022, a total of 2,719 decisions (2,250 federal) have referenced the term "off-label".
+
As of September 25, 2022, a total of 2,719 decisions (2,250 federal) have referenced the term "off-label".  Of those, only 231 decisions (196 federal) discuss the FDA in proximity with the "off-label" term, and many of those cases are class action product liability cases.
 
[[Category:Drugs]]
 
[[Category:Drugs]]
Aschlafly
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,204

edits

Retrieved from "https://www.conservapedia.com/Special:MobileDiff/1888873"

Navigation menu